Filter
528
Filtered Results: 528
Text search:
Artemisinin
Featured
Recommendations
33
New Publications
207
Language
Document type
No document type
306
Studies & Reports
80
Guidelines
54
Strategic & Response Plan
29
Manuals
25
Training Material
13
Fact sheets
12
Resource Platforms
6
Situation Updates
2
Infographics
1
Countries / Regions
Global
31
Kenya
24
Sierra Leone
23
Uganda
23
Liberia
21
Senegal
19
Tanzania
19
Malawi
16
Ghana
15
Nigeria
15
Rwanda
14
Myanmar / Burma
14
Mozambique
13
India
13
Ethiopia
11
Africa
10
Zambia
10
Cameroon
9
Zimbabwe
9
Latin America and the Carribbean
8
Indonesia
8
Madagascar
8
Cambodia
7
Congo, Democratic Republic of
7
Bangladesh
7
South Africa
7
Nepal
6
Benin
4
Burkina Faso
4
South–East Asia Region
4
North America
4
Namibia
4
Mali
4
Guinea
3
Venezuela
3
Vietnam
3
Thailand
2
Philippines
2
Botswana
2
Somalia
2
Eswatini/ Swaziland
2
North Macedonia
1
Colombia
1
Timor Leste/ East Timor
1
Togo
1
China
1
Laos
1
Haiti
1
Asia
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Western and Central Europe
1
Paraguay
1
Turkmenistan
1
France
1
East and Southern Africa
1
Lebanon
1
Papua New Guinea
1
Brazil
1
Sudan
1
Central African Republic
1
Angola
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
326
Clinical Guidelines
34
Public Health
27
Women & Child Health
11
Key Resources
9
Capacity Building
8
Pharmacy & Technologies
6
Toolboxes
Malaria
99
Pharmacy
19
AMR
18
NTDs
11
Health Financing Toolbox
8
Caregiver
6
Planetary Health
6
Global Health Education
6
HIV
5
COVID-19
5
TB
4
Ebola & Marburg
4
NCDs
2
Rapid Response
1
Conflict
1
The reports bring together the latest findings and conclusions about the state of resistance to artemisinins and artemisinin-based combination therapy (ACT), summarize WHO’s current policy and treatment recommendations, and highlight areas of concern.
The framework recommends expanded coverage of malaria diagnostic and treatment services, intensified vector control to drive down transmission, strengthened malaria surveillance, and increased transborder collaboration, especially in terms of efforts to control the sale and use of artemisinin monoth...
Efficacious antimalarial medicines are critical to malaria control and elimination. Continuous monitoring of their efficacy is needed to inform treatment policies in malaria-endemic countries, and to ensure early detection of, and response to, drug resistance.
Malaria in pregnancy is a significant health problem in malaria-endemic areas. It not only causes substantial childhood morbidity and mortality but also increases the risks of adverse events for pregnant women and their developing fetuses. Most of the burden in these areas is due to infection with P...
Pour combattre et éliminer le paludisme, il est essentiel de disposer de médicaments antipaludiques efficaces. Un suivi régulier de l’efficacité des médicaments s’impose pour orienter les politiques de traitement dans les pays d’endémie palustre et assurer la détection précoce de la ph...
Para controlar y eliminar el paludismo (o malaria) es fundamental contar con fármacos antipalúdicos eficaces. Para fundamentar las políticas de tratamiento en los países donde esta enfermedad es endémica, y para garantizar la pronta detección de toda farmacorresistencia y una adecuada respuest...
WHO recommends artemisinin-based combination therapies for treating uncomplicated malaria, alongside studies to monitor treatment effectiveness. Given the threat of antimalarial resistance, including partial resistance in several African countries, molecular tools are vital for tracking resistance. ...
Malar J (2017) 16:174 DOI 10.1186/s12936-017-1808-x
Background: Since 2004, artemisinin-based combination therapy (ACT) has been the first-line treatment for uncomplicated malaria in Benin. In 2016, a medicine outlet survey was implemented to investigate the availability, price, and market share of...
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner drug ...
The fact sheet details transmission methods, symptoms, at-risk populations, diagnostic approaches, treatment options—including the use of artemisinin-based combination therapies (ACTs)—and preventive measures such as insecticide-treated nets (ITNs) and indoor residual spraying (IRS). It also dis...
The TACT training manuals and patient leaflet were developed as part of the ACT Consortium's initiative to improve malaria case management by promoting the correct use of rapid diagnostic tests (RDTs). The TACT ("Targeting ACTs") initiative aims to ensure that artemisinin-based combination therapies...
Depuis 2010, la lutte contre le paludisme a permis de réaliser des progrès majeurs grâce à la distribution de moustiquaires, au diagnostic rapide, aux traitements à base d'artémisinine (ACT) et aux interventions préventives ciblées.
The ACT Consortium was an international research collaboration dedicated to evaluating the effectiveness, safety and implementation of artemisinin-based combination therapies (ACTs) for treating malaria. Operating across multiple countries in Africa and Asia, the consortium conducted over 25 studies...
Os manuais de formação TACT e o folheto para o paciente foram desenvolvidos no âmbito da iniciativa do ACT Consortium para melhorar a gestão dos casos de malária e promover a utilização correta dos testes de diagnóstico rápido (RDT). A iniciativa TACT ("Targeting ACTs") visa garantir a util...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
In the context of the Support to National Malaria Control Programme (SuNMaP), demand creation is the strategic combination of advocacy, communication and mobilisation approaches that seek to achieve increased community awareness of, and demand for, effective malaria prevention and treatment services...
These guidelines are based on the 3rd Edition of the WHO Guidelines (Published 2015) World Health Organization’s Guidelines for the treatment of malaria. Additional literature surveys have been undertaken. Factors that were considered in the choice of therapeutic options included effectiveness, sa...
Malaria is a prevalent cause of febrile illnesses in areas with high transmission, and its clinical presentation overlaps with initial signs of Ebola disease. For this reason, the effectiveness of the Ebola response in Guinea, Liberia and Sierra Leone can be optimized through the deployment of targe...
